Answers are grounded in this paper and cite their sources.
Persistent joint inflammation and pain with concomitant joint erosion, characterize Rheumatoid Arthritis (RA). We used a Fibroblast-like Synovial (FLS) cell line derived from a female rabbit, as a model system for studying the initiation and attenuation of conditions of RA in vitro. We used two pro-inflammatory cytokines, TNF and IL-1 to examine potential inflammatory responses and cartilage erosion exerted by each cytokine alone and/or in combination. We determined the expression levels of cytokine-induced expression of Cyclooxygenase-2 (COX-2), production of Prostaglandin E2 (PGE2), release of high mobility group box-1 (HMGB1) protein and the activity of Metalloproteinase-9 (MMP-9) in FLS cells. Treatment with TNF alone increased HMGB1 release levels, MMP-9 activity, COX-2 expression and PGE2 production in both concentration-and exposure time-dependent manner. But treatment with a low concentration of TNF- in combination with an equivalent concentration of IL-1 produced similar levels of COX-2 expression and PGE2 production compared with the same concentration of TNF- alone. This suggests that the effects observed could only be due to the TNF. IL-1 did not affect COX-2 expression in a concentration-dependent manner compared to media control. Treatment with indomethacin or NS392 significantly decreased TNF-induced COX-2 expression coupled with decreased PGE2 production and MMP-9 expression. In addition, anti-TNF decreased HMGB1 release level, PGE2 production and MMP-9 expression, which support a critical role for TNF-induced TNF Receptor (TNFR) activation for these effects. Overall, our results support treatment approaches in RA that attenuate the effects of TNF-induced TNFR stimulation on MMP-9 and PGE2 production with HMGB1 release for a more efficacious therapy.
No takes yet. Share an insight, caveat, or question.
AA et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: